Leukaemic transformation with romiplostim

Br J Haematol. 2012 Jul;158(2):153. doi: 10.1111/j.1365-2141.2012.09194.x. Epub 2012 Jun 15.

Authors

Kate Gardner¹, Stanford Mathe², Satyajit Sahu¹

Affiliations

¹ Department of Haematology, Eastbourne District General Hospital, Eastbourne, East Sussex, UK.
² Department of Histopathology, Eastbourne District General Hospital, Eastbourne, East Sussex, UK.

PMID: 22702968
DOI: 10.1111/j.1365-2141.2012.09194.x

No abstract available

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Cell Transformation, Neoplastic / drug effects*
Diagnosis, Differential
Fatal Outcome
Female
Humans
Leukemia, Myeloid, Acute / chemically induced*
Leukemia, Myeloid, Acute / pathology
Leukemic Infiltration / chemically induced
Leukemic Infiltration / pathology
Myelodysplastic Syndromes / diagnosis
Myelodysplastic Syndromes / drug therapy
Purpura, Thrombocytopenic, Idiopathic / diagnosis
Receptors, Fc
Receptors, Thrombopoietin / agonists
Recombinant Fusion Proteins / adverse effects*
Skin / pathology
Thrombopoietin / adverse effects*

Substances

Receptors, Fc
Receptors, Thrombopoietin
Recombinant Fusion Proteins
Thrombopoietin
romiplostim